NCT02869828

Brief Summary

Core temperature monitoring is mandatory during major surgery. The accurate techniques currently used are invasive, such as artery catheter and oesophagal probe. A new non-invasive cutaneous device, 3M SpotOn, using Zero Heath-Flux method, continuously measure core temperature. This prospective study compare the accuracy of Zero-Heath-Flux to oesophagal temperature (30 patients) and to artery catheter (20 patients) in adult patients during surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 20, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 17, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

June 19, 2017

Status Verified

June 1, 2016

Enrollment Period

1.6 years

First QC Date

June 20, 2016

Last Update Submit

June 16, 2017

Conditions

Outcome Measures

Primary Outcomes (3)

  • temperature monitoring with Zero-Heath-Flux (SpotOn)

    1 day

  • temperature monitoring with oesophagal probe (Coviden)

    1 day

  • temperature monitoring with arterial catheter (PICCO)

    1 day

Study Arms (2)

monitoring by arterial catheter and Spot-on

OTHER
Device: Monitoring by arterial catheter and Spot-on

monitoring by oesophagus tube and Spot-on

OTHER
Device: Monitoring by oesophagal probe and Spot-on

Interventions

monitoring by arterial catheter and Spot-on
monitoring by oesophagus tube and Spot-on

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled to undergo general anaesthesia for gut surgery lasting more than 2 hours
  • Patients with core temperature monitored with oesophagal probe only (30 patients) or with oesophagal probe and PICCO device (20 patients)
  • Patients without opposition to this study after informations given

You may not qualify if:

  • Patients with frontal cutaneous decay wich avoid using 3M Spot-on
  • Patients whom oesophagal probe was prohibited (oesophagal varices, oesophagal surgery)
  • Pregnant women or breast-feeding, women who may become pregnant unless adequate contraceptive measures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BOISSON Matthieu

Poitiers, 86021, France

Location

Related Publications (1)

  • Boisson M, Alaux A, Kerforne T, Mimoz O, Debaene B, Dahyot-Fizelier C, Frasca D. Intra-operative cutaneous temperature monitoring with zero-heat-flux technique (3M SpotOn) in comparison with oesophageal and arterial temperature: A prospective observational study. Eur J Anaesthesiol. 2018 Nov;35(11):825-830. doi: 10.1097/EJA.0000000000000822.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2016

First Posted

August 17, 2016

Study Start

June 1, 2015

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

June 19, 2017

Record last verified: 2016-06

Locations